Healthcare Global IPO Details – Price, Date, Prospectus, Allotment, Listing

in IPOs, Knowledge 0

Healthcare Global Enterprises Ltd IPO is hitting the markets on Mar 16, 2016. Health care Global is into specialty healthcare primarily for Cancer and fertility. The Company is offering 2,98,00,000 equity share out of which their is a fresh issue of 1,16,00,000 share and offer for sale for remaining 1,82,00,000 shares. The Price band is fixed at Rs. 205 to Rs.218 for each share with its face value of Rs.10.

Bangalore based Healthcare Global Enterprises Ltd (HCG) operates one of largest network of private cancer treatment centers in India. Apart from this, HCG also operates fertility centers under the ‘Milann’ brand.

The company has filed its draft initial public offering (IPO) papers with markets regulator Securities and Exchange Board of India (SEBI), to raise fund over $100 million (approx. Rs.650 crore) as on 9th March 2016. The offer will be helpful to constitute up to 36.83% of the firm’s post-offer paid-up equity share capital. The equity shares would be listed on the BSE and the NSE.

The firm will utilize the primary funds to be raised through the issue for purchase of medical equipment; investment in IT software, services and hardware; pre-payment of debt and general corporate purposes.

The IPO will see the company sell 11.6 million primary shares, while investors in the firm will sell 19.4 million shares as part of an offer for sale.

Three-fourths of the issue has been allocated for institutional investors (QIB), 15 per cent non-institutional investors (HNIs, trusts, family offices, corporates) and the remaining 10 per cent for retail. Up to 60 per cent of the QIB portion may be allocated to anchor investors on discretionary basis, of which one-third will be reserved for domestic mutual funds only (besides an additional 5 per cent outside the anchor portion).

IPO Details

Issue Open Date : Mar 16, 2016

Issue Close Date : Mar 18, 2016

Price Band : Rs. 205 to Rs. 218 per share

Face Value : Rs. 10 per share

Issue Size : 2.98 cr. equity shares ( Rs. 610.90-Rs.694.64 crores)

Minimum Order Quantity : 65 shares

Market Lot : 65 shares

Listing on National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)

HCG IPO Prospectus link

Company profile

Healthcare Global Enterprise Ltd (HCG) is facilitating mainly in Cancer and fertility treatments via the largest cancer care network in India. It has its headquarters in Bangalore.

As of 31 December 2015, HCG’s network consisted of 14 comprehensive cancer centers, including center of excellence in Bangalore, three free-standing diagnostic centers and one day care chemotherapy center across India. HCG runs fertility centers under the ‘Milann’ brand too. The company is also collaborating to the local professionals mostly from the same field who is having minority ownership or revenue or profit sharing arrangements.

Relatively, HCG facilitates clinical reference laboratory services in India with a specialization in oncology, including molecular diagnostic services and genomic testing under ‘Triesta’ brand. Triesta central reference laboratory is located in center of excellence in Bangalore.

Currently, Company is focusing to expand and establish its cancer centers in Africa.

Outlook of the Company

Rating is high to diagnose and treatment of Cancer and Fertility cases.
Achieve a good brand value providing its high level of facilities in the hospitals.
Reaching and increasing new patient registrations across its HCG network and its ‘Milann’ Network.
Easy mode and process to communicate with high skilled and educated physicians.

Registered Office

Registered office of the Company located at

HCG Tower, No. 8, P Kalinga Rao Road, Sampangi Rama Nagar,

Bengaluru 560 027, Karnataka, India

Registrar of Companies/RoC:- Bangalore situated at Karnataka, India

Promoters Of the Company

1) DR. BS Ajai Kumar:- He is 63 years old. He is the Chairman and Chief Executive Officer of our Company. He is a resident Indian national.

2) DR. KS Gopinath:- He is 63 years old. He is experienced in the field of surgical oncology. He has been elected an honorary member of the National Academy of Medical Sciences, India and is a member of the American Society of Clinical Oncology and the Society of Head and Neck Surgeons.

3) DR. Ganesh Nayak:- He is 72 years old. He is presently a director of HCG Senthil and MIMS HCG. He has also been a director of our Company from 2005 to 2015.

4) DR. M Gopichand:- He is 52 years old. He presently also practices at the City Cancer Centre. He was a director of HealthCare Global Vijay Oncology Private Limited which merged with our Company.

5) Dr. BS Ramesh:- He is 63 years old. He is presently also a director on the boards of HCG Medi-Surge, HCG Senthil and MIMS HCG.

Financials

Particulars	For the year/Period ended (Rs. in Million)
Financial Year	31-Mar-15	31-Mar-14	31-Mar-13	31-Mar-12	31-Mar-11
Total Liabilities	7761.69	6886.68	7089.81	5061.79	3627.71
Total Assets	7761.69	6886.68	7089.87	5061.79	3627.71
Total Revenue	5241.90	4553.06	3406.83	2702.17	2161.90
Total Expenses	5171.88	4814.95	3508.28	2730.95	2081.67
Profit After Tax (PAT)	41.23	(320.04)	(108.59)	(31.05)	70.43